135 related articles for article (PubMed ID: 25372276)
1. Imidazopyridine- and purine-thioacetamide derivatives: potent inhibitors of nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1).
Chang L; Lee SY; Leonczak P; Rozenski J; De Jonghe S; Hanck T; Müller CE; Herdewijn P
J Med Chem; 2014 Dec; 57(23):10080-100. PubMed ID: 25372276
[TBL] [Abstract][Full Text] [Related]
2. Nonhydrolyzable ATP analogues as selective inhibitors of human NPP1: a combined computational/experimental study.
Lecka J; Ben-David G; Simhaev L; Eliahu S; Oscar J; Luyindula P; Pelletier J; Fischer B; Senderowitz H; Sévigny J
J Med Chem; 2013 Nov; 56(21):8308-20. PubMed ID: 24083941
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of carbon-11-labeled imidazopyridine- and purine-thioacetamide derivatives as new potential PET tracers for imaging of nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1).
Gao M; Wang M; Zheng QH
Bioorg Med Chem Lett; 2016 Mar; 26(5):1371-5. PubMed ID: 26856922
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel quinazoline-4-piperidinesulfamide derivatives as inhibitors of NPP1.
Forcellini E; Boutin S; Lefebvre CA; Shayhidin EE; Boulanger MC; Rhéaume G; Barbeau X; Lagüe P; Mathieu P; Paquin JF
Eur J Med Chem; 2018 Mar; 147():130-149. PubMed ID: 29427906
[TBL] [Abstract][Full Text] [Related]
5. Thiazolo[3,2-a]benzimidazol-3(2H)-one derivatives: Structure-activity relationships of selective nucleotide pyrophosphatase/phosphodiesterase1 (NPP1) inhibitors.
Lee SY; Perotti A; De Jonghe S; Herdewijn P; Hanck T; Müller CE
Bioorg Med Chem; 2016 Jul; 24(14):3157-65. PubMed ID: 27265686
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation, and docking studies of novel pyrrolo[2,3-b]pyridine derivatives as both ectonucleotide pyrophosphatase/phosphodiesterase inhibitors and antiproliferative agents.
Ullah S; El-Gamal MI; El-Gamal R; Pelletier J; Sévigny J; Shehata MK; Anbar HS; Iqbal J
Eur J Med Chem; 2021 May; 217():113339. PubMed ID: 33744686
[TBL] [Abstract][Full Text] [Related]
7. Substrate-Dependence of Competitive Nucleotide Pyrophosphatase/Phosphodiesterase1 (NPP1) Inhibitors.
Lee SY; Sarkar S; Bhattarai S; Namasivayam V; De Jonghe S; Stephan H; Herdewijn P; El-Tayeb A; Müller CE
Front Pharmacol; 2017; 8():54. PubMed ID: 28261095
[TBL] [Abstract][Full Text] [Related]
8. Identification of adenine-N9-(methoxy)ethyl-β-bisphosphonate as NPP1 inhibitor attenuates NPPase activity in human osteoarthritic chondrocytes.
Nassir M; Arad U; Lee SY; Journo S; Mirza S; Renn C; Zimmermann H; Pelletier J; Sévigny J; Müller CE; Fischer B
Purinergic Signal; 2019 Jun; 15(2):247-263. PubMed ID: 31025169
[TBL] [Abstract][Full Text] [Related]
9. Highly Selective and Potent Ectonucleotide Pyrophosphatase-1 (NPP1) Inhibitors Based on Uridine 5'-P
Zelikman V; Pelletier J; Simhaev L; Sela A; Gendron FP; Arguin G; Senderowitz H; Sévigny J; Fischer B
J Med Chem; 2018 May; 61(9):3939-3951. PubMed ID: 29681152
[TBL] [Abstract][Full Text] [Related]
10. Diadenosine 5',5''-(boranated)polyphosphonate analogues as selective nucleotide pyrophosphatase/phosphodiesterase inhibitors.
Eliahu S; Lecka J; Reiser G; Haas M; Bigonnesse F; Lévesque SA; Pelletier J; Sévigny J; Fischer B
J Med Chem; 2010 Dec; 53(24):8485-97. PubMed ID: 21090681
[TBL] [Abstract][Full Text] [Related]
11. Polyoxometalates--potent and selective ecto-nucleotidase inhibitors.
Lee SY; Fiene A; Li W; Hanck T; Brylev KA; Fedorov VE; Lecka J; Haider A; Pietzsch HJ; Zimmermann H; Sévigny J; Kortz U; Stephan H; Müller CE
Biochem Pharmacol; 2015 Jan; 93(2):171-81. PubMed ID: 25449596
[TBL] [Abstract][Full Text] [Related]
12. Ecto-nucleotide pyrophosphatase/phosphodiesterase as part of a multiple system for nucleotide hydrolysis by platelets from rats: kinetic characterization and biochemical properties.
Fürstenau CR; Trentin Dda S; Barreto-Chaves ML; Sarkis JJ
Platelets; 2006 Mar; 17(2):84-91. PubMed ID: 16421009
[TBL] [Abstract][Full Text] [Related]
13. Quinazoline-4-piperidine sulfamides are specific inhibitors of human NPP1 and prevent pathological mineralization of valve interstitial cells.
Shayhidin EE; Forcellini E; Boulanger MC; Mahmut A; Dautrey S; Barbeau X; Lagüe P; Sévigny J; Paquin JF; Mathieu P
Br J Pharmacol; 2015 Aug; 172(16):4189-99. PubMed ID: 26031197
[TBL] [Abstract][Full Text] [Related]
14. Highly potent and selective ectonucleotide pyrophosphatase/phosphodiesterase I inhibitors based on an adenosine 5'-(α or γ)-thio-(α,β- or β,γ)-methylenetriphosphate scaffold.
Nadel Y; Lecka J; Gilad Y; Ben-David G; Förster D; Reiser G; Kenigsberg S; Camden J; Weisman GA; Senderowitz H; Sévigny J; Fischer B
J Med Chem; 2014 Jun; 57(11):4677-91. PubMed ID: 24846781
[TBL] [Abstract][Full Text] [Related]
15. Large-volume sample stacking with polarity switching for monitoring of nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) reactions by capillary electrophoresis.
Lee SY; Müller CE
Electrophoresis; 2014 Mar; 35(6):855-63. PubMed ID: 24431193
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of sulfonate and sulfamate derivatives possessing benzofuran or benzothiophene nucleus as inhibitors of nucleotide pyrophosphatases/phosphodiesterases and anticancer agents.
Anbar HS; El-Gamal R; Ullah S; Zaraei SO; Al-Rashida M; Zaib S; Pelletier J; Sévigny J; Iqbal J; El-Gamal MI
Bioorg Chem; 2020 Nov; 104():104305. PubMed ID: 33017718
[TBL] [Abstract][Full Text] [Related]
17. New biscoumarin derivatives-cytotoxicity and enzyme inhibitory activities.
Choudhary MI; Fatima N; Khan KM; Jalil S; Iqbal S; Atta-Ur-Rahman
Bioorg Med Chem; 2006 Dec; 14(23):8066-72. PubMed ID: 16919464
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationship study of NPP1 inhibitors based on uracil-N1-(methoxy)ethyl-β-phosphate scaffold.
Nassir M; Pelletier J; Arad U; Arguin G; Khazanov N; Gendron FP; Sévigny J; Senderowitz H; Fischer B
Eur J Med Chem; 2019 Dec; 184():111754. PubMed ID: 31610377
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potentials of ecto-nucleoside triphosphate diphosphohydrolase, ecto-nucleotide pyrophosphatase/phosphodiesterase, ecto-5'-nucleotidase, and alkaline phosphatase inhibitors.
al-Rashida M; Iqbal J
Med Res Rev; 2014 Jul; 34(4):703-43. PubMed ID: 24115166
[TBL] [Abstract][Full Text] [Related]
20. Nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) and its inhibitors.
Lee SY; Müller CE
Medchemcomm; 2017 May; 8(5):823-840. PubMed ID: 30108800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
